LDL reduction in subcutaneous evolocumab after 30 days: Real-world single-center experience

M.K. Othman, Z. Yusof, A.Z. Zakaria,Ismail Muhamad Al Muizz, A.S. Ali Suliman,S. Ibrahim, M.F. Ibrahim,S.A. Hussin, W. Isa WYH

International Journal of Cardiology(2022)

引用 0|浏览2
暂无评分
关键词
subcutaneous evolocumab,ldl,real-world,single-center
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要